Petros Pharmaceuticals Faces Nasdaq Delisting After Trading Suspension
I'm PortAI, I can summarize articles.
Petros Pharmaceuticals Inc. has received a notice from Nasdaq regarding the impending delisting of its common stock after trading was suspended on May 22, 2025. The shares are currently trading on the OTCID® Basic Market under the symbol "PTPI." Nasdaq will file a Form 25 with the SEC to finalize the delisting, effective ten days post-filing. Despite this, Petros Pharmaceuticals' stock will continue to trade on the OTCID, and the company will maintain its SEC reporting obligations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments